Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,092
in 3 filings, $19K under 10b5-1 plans

Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. O'Neill Gilmore Neil −$16K CEO sold 2% of stake
  2. Burkly Linda −$2K EVP, CHIEF SCIENTIFIC OFFICER sold 1% of stake
  3. Parison Amy −$1K SVP, Chief Financial Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-03 Hirsch Andrew Director Grant or award · Stock Option (right to buy) +11,538 11,538
2021-06-03 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +11,538 11,538
2021-03-03 Hopfield Jessica Director Purchase +5,800 $45.51 $264K 22,700
2021-03-02 ROBERTSON MICHELLE Chief Financial Officer Grant or award +10,303 28,735
2021-03-02 ROBERTSON MICHELLE Chief Financial Officer Grant or award · Stock Option (right to buy) +32,197 32,197
2021-03-02 MULLEN JAMES C CEO Purchase +25,000 $46.27 $1.2M 35,000
2021-03-02 MULLEN JAMES C CEO Grant or award · Stock Option (right to buy) +196,637 196,637
2021-02-09 Collins Cynthia CEO Sale −1,262 $66.65 $84K 43,760
2021-01-12 ROBERTSON MICHELLE Chief Financial Officer Sale −1,568 $78.27 $123K 18,432
2020-12-17 Chatterjee Meeta Director Grant or award · Stock Option (right to buy) +23,076 23,076
2020-12-15 Albright Charles EVP/Chief Scientific Officer Option exercise +10,000 $16.51 $165K 34,907
2020-12-15 Albright Charles EVP/Chief Scientific Officer Sale −5,776 $62.74 $362K 29,131
2020-12-15 Albright Charles EVP/Chief Scientific Officer Sale −4,024 $63.84 $257K 25,107
2020-12-15 Albright Charles EVP/Chief Scientific Officer Sale −200 $64.39 $13K 24,907
2020-12-15 Albright Charles EVP/Chief Scientific Officer Option exercise · Stock Option (right to buy) −10,000 145,000
2020-12-09 Albright Charles EVP/Chief Scientific Officer Option exercise +10,000 $16.51 $165K 34,907
2020-12-09 Albright Charles EVP/Chief Scientific Officer Sale −10,000 $45.00 $450K 24,907
2020-12-09 Albright Charles EVP/Chief Scientific Officer Option exercise · Stock Option (right to buy) −10,000 155,000
2020-12-07 Albright Charles EVP/Chief Scientific Officer Option exercise +20,000 $16.51 $330K 44,907
2020-12-07 Albright Charles EVP/Chief Scientific Officer Sale −20,000 $40.02 $800K 24,907

Page 10 of 15 · 283 trades